Immunology companies study and manipulate the immune system to develop therapies, diagnostics and research tools. The field plays a central role in areas such as cancer, infectious disease, autoimmune disorders and vaccine development.
This category includes companies working on:
Browse 158 UK immunology companies below.
In vitro biology CRO for immunology and oncology drug discovery
BioMedha is a pre-clinical contract research organisation specialising in in vitro biology for early-stage drug discovery. The company provides assay development, target…
Specialist distributor of transplant diagnostics and molecular biology products
VH Bio is a specialist distributor of life science research and diagnostic products serving the United Kingdom and Republic of Ireland. The company focuses on four areas:…
Engineered T cell receptor therapies for solid tumour cancers
Adaptimmune is a clinical-stage biopharmaceutical company developing engineered T cell receptor therapies targeting solid tumours. The company's T-cell platform engineers T cell…
Automated molecular diagnostics for HLA typing and blood group testing
MC Diagnostics is a specialist molecular diagnostics company developing and manufacturing automated multiplexed assay solutions for clinical and reference laboratories. The…
Single-molecule counting point-of-care diagnostics for cardiac and other biomarkers
Psyros Diagnostics develops a point-of-care diagnostic system using single-molecule counting technology to measure biomarkers at extremely low concentrations within around ten…
Preclinical mRNA nanoparticle therapeutics for chronic inflammatory disease
EVolution Therapeutics is a preclinical-stage biotechnology company developing mRNA nanoparticle and hydrogel-based therapeutics to resolve chronic inflammation and support tissue…
Precision cancer vaccines to prevent metastatic recurrence
Infinitopes is a clinical-stage biotechnology company developing therapeutic cancer vaccines designed to prevent metastatic recurrence. Its lead candidate ITOP1 is a precision…
Immunometabolism-targeting small molecules for autoimmune disease
Sitryx Therapeutics is a clinical-stage biopharmaceutical company developing oral small molecule therapeutics that modulate immune cell metabolism to achieve disease remission in…
Next-generation kinase inhibitors for autoimmune disease and cancer
Sareum is a clinical-stage biotechnology company developing small molecule kinase inhibitors for the treatment of autoimmune diseases and cancer. The company's pipeline centres on…
Bacterial-like particle vaccine platform targeting recurrent UTIs
Spectre Bio is a biotechnology company developing a non-antibiotic prophylactic vaccine for recurrent UTIs, a major unmet medical need and significant driver of antimicrobial…
Monoclonal antibodies for viral infectious disease
RQ Biotechnology is a passive immunisation company discovering and developing long-acting monoclonal antibodies to provide immediate protection against viral infections in…
Topical peptide therapeutics targeting inflammatory skin disease
Carocell Bio is a pre-clinical stage biotechnology company developing proprietary peptide-based therapeutics for inflammatory diseases. Its pipeline centres on topical…